Techcyte

Techcyte is a private, commercial-stage company offering an FDA-cleared and CE-IVDR-certified AI platform for digital pathology. Its flagship product, Techcyte Fusion, integrates anatomic and clinical pathology into a single software solution, featuring AI tools for tasks like cervical cytology screening, parasitology, and bacteriology analysis. The company has established strategic collaborations with major institutions like Mayo Clinic Platform and ESP BD, positioning itself as a key player in the digital diagnostics transformation. It operates on a diagnostics business model, generating revenue through its software platform and associated solutions.

Techcyte Fusion: A unified, cloud-based AI software platform for anatomic and clinical digital pathology. It integrates image management, a suite of deep learning algorithms for various diagnostic applications (cytology, microbiology, hematology, histology), customizable workflows, and LIS connectivity. The platform is scanner-agnostic and built for security and scalability.

Techcyte competes in the digital pathology AI market against large players like Roche (VENTANA DP 200/600, AI partnerships), Philips (IntelliSite), and Proscia, as well as numerous specialized AI startups (e.g., PathAI, Paige). Its key differentiation is the unified AP/CP platform approach, aiming to be a single-vendor solution for the entire lab, unlike many point-solution competitors.